{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:04:20Z","timestamp":1769105060771,"version":"3.49.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion","doi-asserted-by":"crossref","award":["ENB\u2013010\u201310 study"],"award-info":[{"award-number":["ENB\u2013010\u201310 study"]}],"id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006396","name":"Alexion","doi-asserted-by":"crossref","award":["ENB\u2013010\u201310 study"],"award-info":[{"award-number":["ENB\u2013010\u201310 study"]}],"id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sfnmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.siny.2019.101075","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T20:43:30Z","timestamp":1576269810000},"page":"101075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Current status in therapeutic interventions of neonatal bone mineral metabolic disorders"],"prefix":"10.1016","volume":"25","author":[{"given":"Amish","family":"Chinoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Zulf","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Padidela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.siny.2019.101075_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/03014469400003542","article-title":"Body composition of the preterm infant","volume":"21","author":"Ellis","year":"1994","journal-title":"Ann Hum Biol"},{"issue":"4","key":"10.1016\/j.siny.2019.101075_bib2","first-page":"329","article-title":"Body composition of the reference fetus","volume":"40","author":"Ziegler","year":"1976","journal-title":"Growth"},{"issue":"1","key":"10.1016\/j.siny.2019.101075_bib3","first-page":"107","article-title":"Determinants of severe metabolic bone disease in very low-birth-weight infants with severe bronchopulmonary dysplasia admitted to a tertiary referral center","volume":"33","author":"Jensen","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.siny.2019.101075_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.earlhumdev.2017.06.010","article-title":"Risk factors of metabolic bone disease of prematurity","volume":"112","author":"Ukarapong","year":"2017","journal-title":"Early Hum Dev"},{"issue":"8","key":"10.1016\/j.siny.2019.101075_bib5","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1177\/0148607113499590","article-title":"Metabolic bone disease: a continued challenge in extremely low birth weight infants","volume":"38","author":"Viswanathan","year":"2014","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"5","key":"10.1016\/j.siny.2019.101075_bib6","doi-asserted-by":"crossref","first-page":"e1676","DOI":"10.1542\/peds.2013-0420","article-title":"Calcium and vitamin d requirements of enterally fed preterm infants","volume":"131","author":"Abrams","year":"2013","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.siny.2019.101075_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPG.0b013e3181adaee0","article-title":"Enteral nutrient supply for preterm infants: commentary from the European society of paediatric Gastroenterology, Hepatology and nutrition committee on nutrition","volume":"50","author":"Agostoni","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"Suppl 2","key":"10.1016\/j.siny.2019.101075_bib8","first-page":"S1","volume":"41","author":"Koletzko","year":"2005","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.siny.2019.101075_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/0148607113487216","article-title":"A.S.P.E.N.Clinical guidelines: nutrition support of neonatal patients at risk for metabolic bone disease","volume":"37","author":"Nehra","year":"2013","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"4","key":"10.1016\/j.siny.2019.101075_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3476(95)70127-3","article-title":"Effect of physical activity on bone mineralization in premature infants","volume":"127","author":"Moyer-Mileur","year":"1995","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.siny.2019.101075_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1123\/pes.2017-0017","article-title":"The role of exercise in prevention and treatment of osteopenia of prematurity: an update","volume":"29","author":"Eliakim","year":"2017","journal-title":"Pediatr Exerc Sci"},{"issue":"4","key":"10.1016\/j.siny.2019.101075_bib12","first-page":"CD005387","article-title":"Physical activity programs for promoting bone mineralization and growth in preterm infants","author":"Schulzke","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.siny.2019.101075_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1891\/0730-0832.35.2.95","article-title":"Osteopenia of prematurity: does physical activity improve bone mineralization in preterm infants?","volume":"35","author":"Stalnaker","year":"2016","journal-title":"Neonatal Netw"},{"issue":"6","key":"10.1016\/j.siny.2019.101075_bib14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1203\/00006450-199106010-00018","article-title":"Dual tracer stable isotopic assessment of calcium absorption and endogenous fecal excretion in low birth weight infants","volume":"29","author":"Abrams","year":"1991","journal-title":"Pediatr Res"},{"issue":"1 Pt 2","key":"10.1016\/j.siny.2019.101075_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0022-3476(88)80617-6","article-title":"Mineral balance studies in very low birth weight infants fed human milk","volume":"113","author":"Schanler","year":"1988","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.siny.2019.101075_bib16","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1111\/jpc.12052","article-title":"Parathyroid hormone levels in neonates with suspected osteopenia","volume":"49","author":"Moreira","year":"2013","journal-title":"J\u00a0Paediatr Child Health"},{"issue":"5","key":"10.1016\/j.siny.2019.101075_bib17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/archdischild-2018-316330","article-title":"Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences","volume":"104","author":"Chinoy","year":"2019","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"10.1016\/j.siny.2019.101075_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1651-2227.2007.00721.x","article-title":"Osteopenia of prematurity: a national survey and review of practice","volume":"97","author":"Harrison","year":"2008","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.siny.2019.101075_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/adc.56.2.144","article-title":"Plasma 25-hydroxyvitamin D concentrations in preterm infants receiving oral vitamin D supplements","volume":"56","author":"Robinson","year":"1981","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.siny.2019.101075_bib20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1210\/jc.2015-2175","article-title":"Global consensus recommendations on prevention and management of nutritional rickets","volume":"101","author":"Munns","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.siny.2019.101075_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.siny.2013.01.005","article-title":"Maternal vitamin D deficiency: fetal and neonatal implications","volume":"18","author":"Kovacs","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6216","key":"10.1016\/j.siny.2019.101075_bib22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/bmj.280.6216.751","article-title":"Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth","volume":"280","author":"Brooke","year":"1980","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.siny.2019.101075_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/bmb\/ldy010","article-title":"Maternal vitamin D supplementation during pregnancy","volume":"126","author":"Curtis","year":"2018","journal-title":"Br Med Bull"},{"issue":"2","key":"10.1016\/j.siny.2019.101075_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/tropej\/fmp063","article-title":"Nineteen cases of symptomatic neonatal hypocalcemia secondary to vitamin D deficiency: a 2-year study","volume":"56","author":"Teaema","year":"2010","journal-title":"J\u00a0Trop Pediatr"},{"issue":"6","key":"10.1016\/j.siny.2019.101075_bib25","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.siny.2019.101075_bib26","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/apa.12743","article-title":"Activating calcium-sensing receptor gene variants in children: a case study of infant hypocalcaemia and literature review","volume":"103","author":"Thim","year":"2014","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.siny.2019.101075_bib27","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1210\/jc.2015-3910","article-title":"Management of hypoparathyroidism: present and future","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.siny.2019.101075_bib28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/01926230601072301","article-title":"Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats","volume":"34","author":"Jolette","year":"2006","journal-title":"Toxicol Pathol"},{"issue":"3","key":"10.1016\/j.siny.2019.101075_bib29","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol Pathol"},{"issue":"12","key":"10.1016\/j.siny.2019.101075_bib30","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years","volume":"27","author":"Andrews","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1016\/j.siny.2019.101075_bib31","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.siny.2019.101075_bib32","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-2552","article-title":"Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism","volume":"93","author":"Winer","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.siny.2019.101075_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2014.04.060","article-title":"Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism","volume":"165","author":"Winer","year":"2014","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.siny.2019.101075_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jpeds.2011.09.022","article-title":"Recombinant parathyroid hormone therapy for severe neonatal hypoparathyroidism","volume":"160","author":"Cho","year":"2012","journal-title":"J\u00a0Pediatr"},{"issue":"16","key":"10.1016\/j.siny.2019.101075_bib35","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMc063043","article-title":"Recombinant PTH for initial management of neonatal hypocalcemia","volume":"356","author":"Newfield","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.siny.2019.101075_bib36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/01926230490462138","article-title":"Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose","volume":"32","author":"Vahle","year":"2004","journal-title":"Toxicol Pathol"},{"issue":"21","key":"10.1016\/j.siny.2019.101075_bib37","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1111\/bph.14086","article-title":"Calcimimetic and calcilytic therapies for inherited disorders of the calcium-sensing receptor signalling pathway","volume":"175","author":"Hannan","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.siny.2019.101075_bib38","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/jbmr.3747","article-title":"Treatment of autosomal dominant hypocalcemia type 1 with the calcilytic NPSP795 (SHP635)","volume":"34","author":"Roberts","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.siny.2019.101075_bib39","doi-asserted-by":"crossref","first-page":"e812","DOI":"10.1542\/peds.2011-0128","article-title":"Successful use of bisphosphonate and calcimimetic in neonatal severe primary hyperparathyroidism","volume":"129","author":"Wilhelm-Bals","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2019.101075_bib40","first-page":"150040","article-title":"Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients","volume":"2015","author":"Fisher","year":"2015","journal-title":"Endocrinol Diab Metab Case Rep"},{"issue":"5","key":"10.1016\/j.siny.2019.101075_bib41","doi-asserted-by":"crossref","first-page":"F419","DOI":"10.1136\/archdischild-2014-306069","article-title":"Severe hypercalcaemia due to subcutaneous fat necrosis: presentation, management and complications","volume":"99","author":"Shumer","year":"2014","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9","key":"10.1016\/j.siny.2019.101075_bib42","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1515\/jpm-2019-0172","article-title":"Subcutaneous fat necrosis, a rare but serious side effect of hypoxic-ischemic encephalopathy and whole-body hypothermia","volume":"47","author":"Alsaleem","year":"2019","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.siny.2019.101075_bib43","article-title":"Vitamin D toxicity in young breastfed infants: report of 2 cases","volume":"4","author":"Bilbao","year":"2017","journal-title":"Glob Pediatr Health"},{"issue":"4","key":"10.1016\/j.siny.2019.101075_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MNH.0000000000000238","article-title":"Mechanisms and causes of hypomagnesemia","volume":"25","author":"Agus","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"10.1016\/j.siny.2019.101075_bib45","first-page":"282","article-title":"Neonatal magnesium disturbances","volume":"124","author":"Tsang","year":"1972","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.siny.2019.101075_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-216870","article-title":"Familial hypomagnesaemia with secondary hypocalcaemia","volume":"2016","author":"Patel","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"10","key":"10.1016\/j.siny.2019.101075_bib47","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1681\/ASN.2004110989","article-title":"Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia","volume":"16","author":"Schlingmann","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.siny.2019.101075_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/adc.78.2.127","article-title":"Clinical presentation and outcome in primary familial hypomagnesaemia","volume":"78","author":"Shalev","year":"1998","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.siny.2019.101075_bib49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00041552-200207000-00006","article-title":"Magnesium and the parathyroid","volume":"11","author":"Vetter","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"10.1016\/j.siny.2019.101075_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2213-8587(18)30307-3","article-title":"Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.siny.2019.101075_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2350\/07-06-0297.1","article-title":"Idiopathic infantile arterial calcification: the spectrum of clinical presentations","volume":"11","author":"Chong","year":"2008","journal-title":"Pediatr Dev Pathol"},{"issue":"2","key":"10.1016\/j.siny.2019.101075_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCGENETICS.108.797704","article-title":"Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy","volume":"1","author":"Rutsch","year":"2008","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.siny.2019.101075_bib53","author":"Turbiville"},{"key":"10.1016\/j.siny.2019.101075_bib54","doi-asserted-by":"crossref","first-page":"10006","DOI":"10.1038\/ncomms10006","article-title":"ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy","volume":"6","author":"Albright","year":"2015","journal-title":"Nat Commun"},{"issue":"10028","key":"10.1016\/j.siny.2019.101075_bib55","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","article-title":"Osteogenesis imperfecta","volume":"387","author":"Forlino","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.siny.2019.101075_bib56","series-title":"Genetics of bone biology and skeletal disease","first-page":"397","article-title":"Chapter 23 - osteogenesis imperfecta","author":"Marini JCC","year":"2018"},{"issue":"6","key":"10.1016\/j.siny.2019.101075_bib57","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/gim.2015.131","article-title":"Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta","volume":"18","author":"Bellur","year":"2016","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.siny.2019.101075_bib58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000351374","article-title":"Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of age","volume":"79","author":"Alcausin","year":"2013","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"10.1016\/j.siny.2019.101075_bib59","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00774-014-0618-2","article-title":"Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age","volume":"33","author":"Kusumi","year":"2015","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"5","key":"10.1016\/j.siny.2019.101075_bib60","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/adc.2007.125468","article-title":"Two doses of pamidronate in infants with osteogenesis imperfecta","volume":"93","author":"Senthilnathan","year":"2008","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.siny.2019.101075_bib61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bone.2004.03.008","article-title":"Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta","volume":"35","author":"Munns","year":"2004","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.siny.2019.101075_bib62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13023-018-0905-4","article-title":"Consensus statement on physical rehabilitation in children and adolescents with osteogenesis imperfecta","volume":"13","author":"Mueller","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.siny.2019.101075_bib63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40778-018-0118-8","article-title":"Fetal mesenchymal stromal cells: an opportunity for prenatal cellular therapy","volume":"4","author":"Sagar","year":"2018","journal-title":"Curr Stem Cell Rep"},{"issue":"12","key":"10.1016\/j.siny.2019.101075_bib64","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/ajmg.a.61366","article-title":"Nosology and classification of genetic skeletal disorders: 2019 revision","volume":"179","author":"Mortier","year":"2019","journal-title":"Am J Med Genet A"},{"issue":"5","key":"10.1016\/j.siny.2019.101075_bib65","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.beem.2018.06.003","article-title":"Sclerosing bone dysplasias","volume":"32","author":"Boudin","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.siny.2019.101075_bib66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fendo.2019.00085","article-title":"One disease, many genes: implications for the treatment of osteopetroses","volume":"10","author":"Penna","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.siny.2019.101075_bib67","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clp.2015.03.003","article-title":"Skeletal dysplasias","volume":"42","author":"Krakow","year":"2015","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.siny.2019.101075_bib68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.rmed.2017.07.063","article-title":"Skeletal dysplasia: respiratory management during infancy","volume":"131","author":"Alapati","year":"2017","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.siny.2019.101075_bib69","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0022-3476(84)81092-6","article-title":"Apnea and sudden unexpected death in infants with achondroplasia","volume":"104","author":"Pauli","year":"1984","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.siny.2019.101075_bib70","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0022-3476(87)80542-5","article-title":"Cervicomedullary compression in young patients with achondroplasia: value of comprehensive neurologic and respiratory evaluation","volume":"110","author":"Reid","year":"1987","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.siny.2019.101075_bib71","first-page":"732","article-title":"Prospective assessment of risks for cervicomedullary-junction compression in infants with achondroplasia","volume":"56","author":"Pauli","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.siny.2019.101075_bib72","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1542\/peds.2005-1440","article-title":"Health supervision for children with achondroplasia","volume":"116","author":"Trotter","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.siny.2019.101075_bib73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.a.37394","article-title":"Best practices in the evaluation and treatment of foramen magnum stenosis in achondroplasia during infancy","volume":"170A","author":"White","year":"2016","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.siny.2019.101075_bib74","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/adc.2010.189092","article-title":"Clinical management of achondroplasia","volume":"97","author":"Wright","year":"2012","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.siny.2019.101075_bib75","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/01241398-199711000-00006","article-title":"Prevention of fixed, angular kyphosis in achondroplasia","volume":"17","author":"Pauli","year":"1997","journal-title":"J\u00a0Pediatr Orthop"},{"issue":"1","key":"10.1016\/j.siny.2019.101075_bib76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000446958","article-title":"Height outcome of recombinant human growth hormone treatment in achondroplasia children: a meta-analysis","volume":"86","author":"Miccoli","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"10.1016\/j.siny.2019.101075_bib77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJMoa1813446","article-title":"C-type natriuretic peptide analogue therapy in children with achondroplasia","volume":"381","author":"Savarirayan","year":"2019","journal-title":"N\u00a0Engl J Med"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X19301118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X19301118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:44:11Z","timestamp":1761677051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X19301118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1744165X19301118"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2019.101075","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status in therapeutic interventions of neonatal bone mineral metabolic disorders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2019.101075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101075"}}